Design, conduct, and interpretation of organ impairment studies in oncology patients

J Clin Oncol. 2006 Jul 20;24(21):3509-10; author reply 3510-1. doi: 10.1200/JCO.2006.06.6795.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage
  • Antimetabolites, Antineoplastic / adverse effects*
  • Clinical Trials as Topic / standards
  • Dietary Supplements*
  • Drug Administration Schedule
  • Folic Acid / administration & dosage*
  • Folic Acid Antagonists / administration & dosage
  • Folic Acid Antagonists / adverse effects*
  • Glomerular Filtration Rate / drug effects*
  • Glutamates / administration & dosage
  • Glutamates / adverse effects*
  • Guanine / administration & dosage
  • Guanine / adverse effects
  • Guanine / analogs & derivatives*
  • Humans
  • Kidney / drug effects*
  • Kidney / physiopathology
  • Pemetrexed
  • Research Design

Substances

  • Antimetabolites, Antineoplastic
  • Folic Acid Antagonists
  • Glutamates
  • Pemetrexed
  • Guanine
  • Folic Acid